Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on AIRO Group (AIRO)
-
Cantor Fitzgerald Reiterates Overweight Rating on AeroVironment (AVAV)
-
Cantor Fitzgerald Reiterates Overweight Rating on Kratos Defense & Security (KTOS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Redwire (RDW)
-
Cantor Fitzgerald Reiterates Overweight Rating on Sanara MedTech (SMTI)
-
Cantor Fitzgerald Starts Oklo (OKLO) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Coinbase Global Inc. (COIN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)
-
Cantor Fitzgerald Reiterates Overweight Rating on VinFast Auto Ltd. (VFS)
-
Cantor Fitzgerald Reiterates Neutral Rating on Polestar Automotive Holding Uk Plc (PSNY)
-
Cantor Fitzgerald Reiterates Neutral Rating on Lucid Group Inc. (LCID)
-
Cantor Fitzgerald Reiterates Neutral Rating on Rivian Automotive Inc (RIVN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
Cantor Fitzgerald Reiterates Overweight Rating on TruBridge Inc (TBRG)
-
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT)
-
Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Almonty prices $90 million public offering, lists on NASDAQ
-
Almonty Announces Nasdaq Listing Concurrent with Pricing of US$90 Million Upsized, Oversubscribed Public Offering
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
Cantor Fitzgerald Reiterates Overweight Rating on WAVE Life Sciences (WVE)
-
Cantor Fitzgerald Starts Tvardi Therapeutics Inc (TVRD) at Overweight
-
Cantor Fitzgerald Starts Harrow Health (HROW) at Overweight
-
Cantor Fitzgerald Starts Inova Technology, Inc. (INVA) at Overweight
-
Cantor Equity Partners, Inc. and Twenty One Capital, Inc. Announce Filing of Draft Registration Statement on Form S-4 with the SEC
-
Soleno Therapeutics prices $200 million stock offering at $85 per share
-
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on HubSpot Inc (HUBS)
-
Cantor Fitzgerald Reiterates Overweight Rating on salesforce.com (CRM)
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $29 at Cantor Fitzgerald
-
Cantor Fitzgerald Raises Price Target on Bitdeer Technologies Group (BTDR) to $23
-
Cantor Fitzgerald Reiterates Overweight Rating on Eledon Pharamceuticals (ELDN)
-
Cantor Fitzgerald Reiterates Neutral Rating on Merck (MRK)
-
Cantor Fitzgerald Reiterates Overweight Rating on Apellis Pharmaceuticals (APLS)
-
Trilogy Metals Reports Second Quarter Fiscal 2025 Financial Results and Provides Updated Cash Position
-
Orchid Island Capital declares $0.12 July dividend, reports Q2 loss
-
Orchid Island Capital Announces Estimated Second Quarter 2025 Results, July 2025 Monthly Dividend and June 30, 2025 RMBS Portfolio Characteristics
-
BitMine closes $250 million private placement for Ethereum treasury
-
BitMine Immersion Technologies Closes $250 Million Private Placement to Advance its Treasury Strategy on Ethereum
-
Cantor Fitzgerald Starts AeroVironment (AVAV) at Overweight
-
Cantor Fitzgerald Starts AIRO Group (AIRO) at Overweight
-
BioSig Technologies secures up to $1.1 billion in growth financing
-
ReserveOne announces $1 billion SPAC merger with M3-Brigade
-
ReserveOne Sets Out to Build the Digital Reserve of the Future
-
WCAS ANNOUNCES STRATEGIC GROWTH INVESTMENT IN AIA CONTRACT DOCUMENTS, THE GOLD STANDARD FOR RISK MANAGEMENT WITHIN THE CONSTRUCTION INDUSTRY
-
Cantor Fitzgerald Reiterates Overweight Rating on Redwire (RDW)
-
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
-
BioSig Technologies, Inc. and Streamex Exchange Corporation Announce Definitive Agreements for up to $1.1B USD in Growth Financing to Launch Gold Backed Treasury Management Strategy and to Rapidly Exp
-
Cantor Fitzgerald Downgrades Jasper Therapeutics (JSPR) to Neutral, 'Scratching our Heads with Today’s Briq’ Update'
-
Palisades Closes Multi-Originator Home Equity Investment Securitization
-
Almonty applies to list on Nasdaq concurrent with US public offering
-
Almonty Announces Application to List on Nasdaq Capital Market Concurrent with Launch of U.S. Public Offering
